Fresh Tracks Therapeutics | 4:持股变动声明-股东 Exploration Capital, LLC
Fresh Tracks Therapeutics | SC 13D:超过5%持股股东披露文件-Stephen L. Gustin(21.3%),Exploration Capital, LLC(20.5%)
Fresh Tracks Therapeutics | 4:持股变动声明-股东 Exploration Capital, LLC
Fresh Tracks Therapeutics | 4:持股变动声明-股东 Exploration Capital, LLC
Fresh Tracks Therapeutics | 4:持股变动声明-股东 Exploration Capital, LLC
Fresh Tracks Therapeutics | 4:持股变动声明-股东 Exploration Capital, LLC
Fresh Tracks Therapeutics | 4:持股变动声明-股东 Exploration Capital, LLC
Fresh Tracks Therapeutics | 4:持股变动声明-股东 Exploration Capital, LLC
Fresh Tracks Therapeutics | 4:持股变动声明-股东 Exploration Capital, LLC
Fresh Tracks Therapeutics | 4:持股变动声明-股东 Exploration Capital, LLC
Fresh Tracks Therapeutics | 4:持股变动声明-股东 Exploration Capital, LLC
Fresh Tracks Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Stephen L. Gustin(15.0%),Exploration Capital, LLC(14.2%)
Fresh Tracks Therapeutics | 4:持股变动声明-股东 Exploration Capital, LLC
Fresh Tracks Therapeutics | 4:持股变动声明-股东 Exploration Capital, LLC
Fresh Tracks Therapeutics | 4:持股变动声明-高管 Fox-Collis Aaron
Fresh Tracks Therapeutics | 4:持股变动声明-高管 Marchio Albert N II
Fresh Tracks Therapeutics | 4:持股变动声明-股东 Exploration Capital, LLC
Fresh Tracks Therapeutics | 4:持股变动声明-股东 Exploration Capital, LLC
Fresh Tracks Therapeutics | 4:持股变动声明-高管 Chadha Deepak
Fresh Tracks Therapeutics | 4:持股变动声明-高管 Fox-Collis Aaron
暂无数据